tailieunhanh - The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review

Lung cancer is the leading cause of deaths with million cases and ranks fifth in the incidence of cancer in human ( million) according to 2017 statistics worldwide and emerges as a global health burden. | The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN